Private equity firm Bridgepoint is reportedly considering a takeover approach for AMS, a medical technology group listed on the London Stock Exchange. The potential deal values the company at approximately £550 million. AMS specializes in medical devices and solutions, particularly in urology and women's health sectors. This move comes as private equity firms continue to show strong interest in healthcare assets, seeking stable returns in the medical technology space. If the bid proceeds, it would mark another significant delisting of a UK healthcare company. Market watchers are now waiting to see whether AMS's board will engage with the preliminary proposal.